These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 36210812)

  • 1. The controversy of klotho as a potential biomarker in chronic kidney disease.
    Yu LX; Li SS; Sha MY; Kong JW; Ye JM; Liu QF
    Front Pharmacol; 2022; 13():931746. PubMed ID: 36210812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease-Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows.
    Martín-Vírgala J; Martín-Carro B; Fernández-Villabrille S; Ruiz-Torres MP; Gómez-Alonso C; Rodríguez-García M; Fernández-Martín JL; Alonso-Montes C; Panizo S; Cannata-Andía JB; Naves-Díaz M; Carrillo-López N
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphate and Klotho.
    Kuro-O M
    Kidney Int; 2011 Apr; 79121():S20-3. PubMed ID: 26746857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the reference interval for urinary klotho to creatinine ratio of healthy dogs.
    Marečáková N; Kačírová J; Tóthová C; Maďari A; Maďar M; Farbáková J; Horňák S
    Front Vet Sci; 2024; 11():1423390. PubMed ID: 39113723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphate and Klotho.
    Kuro-O M
    Kidney Int Suppl; 2011 Apr; 79(121):S20-3. PubMed ID: 21346722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of klotho in chronic kidney disease.
    Zou D; Wu W; He Y; Ma S; Gao J
    BMC Nephrol; 2018 Oct; 19(1):285. PubMed ID: 30348110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease.
    Kitagawa M; Sugiyama H; Morinaga H; Inoue T; Takiue K; Ogawa A; Yamanari T; Kikumoto Y; Uchida HA; Kitamura S; Maeshima Y; Nakamura K; Ito H; Makino H
    PLoS One; 2013; 8(2):e56695. PubMed ID: 23431388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
    Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease.
    Yi HJ; Lee JB; Lee KP; Oh YI; Song KH; Seo KW
    BMC Vet Res; 2020 Jul; 16(1):246. PubMed ID: 32677951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF23 and Klotho in chronic kidney disease.
    Olauson H; Larsson TE
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):397-404. PubMed ID: 23666415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
    Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease.
    Lu X; Hu MC
    Kidney Dis (Basel); 2017 Jul; 3(1):15-23. PubMed ID: 28785560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential application of Klotho as a prognostic biomarker for patients with diabetic kidney disease: a meta-analysis of clinical studies.
    Yu LX; Sha MY; Chen Y; Tan F; Liu X; Li S; Liu QF
    Ther Adv Chronic Dis; 2023; 14():20406223231213246. PubMed ID: 38058396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble α -Klotho Serum Levels in Chronic Kidney Disease.
    Rotondi S; Pasquali M; Tartaglione L; Muci ML; Mandanici G; Leonangeli C; Sales S; Farcomeni A; Mazzaferro S
    Int J Endocrinol; 2015; 2015():872193. PubMed ID: 25873958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Protective Role of Klotho in CKD-Associated Cardiovascular Disease.
    Bi X; Yang K; Zhang B; Zhao J
    Kidney Dis (Basel); 2020 Nov; 6(6):395-406. PubMed ID: 33313060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
    Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y
    Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of Klotho Protein for Managing Kidney Disease - an Emerging Role in Therapeutics and Molecular Medicine.
    Ray SK; Masarkar N; Mukherjee S
    Curr Mol Med; 2021; 21(6):484-494. PubMed ID: 33222666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klotho/FGF23 Axis in CKD.
    Tsuchiya K; Nagano N; Nitta K
    Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Klotho safeguards platelet lifespan in advanced chronic kidney disease through restraining Bcl-xL ubiquitination and degradation.
    Lan Q; Du C; Xiong J; Wu Y; Liao W; Liu C; Chen J; Ran L; Wang Y; Wang Y; Wang J; Zhao J; Yang K
    J Thromb Haemost; 2022 Dec; 20(12):2972-2987. PubMed ID: 36087344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.